Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus

Modern Rheumatology

Volumn 22, Issue 2, 2012, Pages 308-311

  Kikuchi, Hirotoshi ^a   Yamamoto, Tadashi ^a   Asako, Kurumi ^a   Takayama, Maki ^a   Shirasaki, Ryosuke ^a   Ono, Yasuo ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD64; Etanercept; Hemophagocytic syndrome; Procalcitonin; Systemic lupus erythematosus

Indexed keywords

CYCLOSPORIN A; ETANERCEPT; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG MEGADOSE; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; FOLLOW UP; HEMOPHAGOCYTIC SYNDROME; HUMAN; HUMAN TISSUE; PANCYTOPENIA; PRIORITY JOURNAL; SCINTIGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SUBCUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; METHOTREXATE; PREDNISOLONE; PULSE THERAPY, DRUG; RECEPTORS, TUMOR NECROSIS FACTOR; REMISSION INDUCTION; TREATMENT FAILURE;

EID: 84861475798     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-011-0500-1     Document Type: Article

References (15)

1. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmune Rev. 2004;3:69-75. (Pubitemid 38293367)
2. Wong KF, Hui PK, Chan JKC, Chan YW, Ha SY. The acute lupus hemophagocytic syndrome. Ann Intern Med. 1991;114:387-90.
3. Kumakura S, Ishikura H, Kondo M, Murakawa Y, Masuda J, Kobayashi S. Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol. 2004;14:205-15. (Pubitemid 39206664)
4. Qian J, Yang CD. Hemophagocytic syndrome as one of main manifestations in untreated systemic lupus erythematosus: two case reports and literature review. Clin Rheumatol. 2007;26:807-10. (Pubitemid 46554101)
5. Lambotte O, Khellaf M, Harmouche H, Bader-Meunier B, Manceron V, Goujard C, et al. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome. Medicine. 2006;85:169-82. (Pubitemid 43833015)
6. Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol. 2008;22:773-92.
7. Ideguchi H, Ohno S, Takase K, Hattori H, Kirino Y, Takeno M, et al. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab. Rheumatology. 2007;46:1621-2. (Pubitemid 47500586)
8. Henzan T, Nagafuji K, Tsukamoto H, Miyamoto T, Gondo H, Imashuku S, Harada M. Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol. 2006;81:59-61. (Pubitemid 43077214)
9. Takahashi N, Naniwa T, Banno S. Successful use of etanercept in the treatment of acute lupus hemophagocytic syndrome. Mod Rheumatol. 2008;18:72-5.
10. Aouba A, De Bandt M, Aslangul E, Atkhen N, Patri B. Haemophagocytic syndrome in a rheumatoid arthritis patient treated with infliximab. Rheumatology. 2003;42:800-2. (Pubitemid 37220916)
11. Ramanan AV, Schneider R. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol. 2003;30:401-3. (Pubitemid 36152611)
12. Matsui T, Ohsumi K, Ozawa N, Shimada K, Sumitomo S, Shimane K, et al. CD64 on neutrophils is a sensitive and specific marker for detection of infection in patients with rheumatoid arthritis. J Rheumatol. 2006;33:2416-24. (Pubitemid 46067820)
13. Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, et al. Multicenter prospective study of procalcitonin as an indicator of sepsis. J Infect Chemother. 2005;11:152-9. (Pubitemid 40933683)
14. Osugi Y, Hara J, Tagawa S, Takai K, Hosoi G, Matsuda Y, et al. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood. 1997;89:4100-3. (Pubitemid 27220957)
15. Billiau AD, Roskams T, Damme-Lombaerts RV, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-γ-producing lymphocytes and IL-6- and TNF-α-producing macrophages. Blood. 2005;105:1648-51. (Pubitemid 40223686)